[Synergistic antiproliferative effect of DFMO in combination with beta-interferon on human gastric cancer in vitro].
D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D000518:Eflornithine / Q000627:therapeutic use*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000628:therapy*
D007370:Interferon Type I; D000518:Eflornithine